Pharmacy Times May 13, 2021
Aislinn Antrim, Associate Editor

Policy changes impacting the star ratings for 2022 include additional flexibility provided during the COVID-19 pandemic and a revised Extreme and Uncontrollable Circumstances policy.

Because the Centers for Medicare and Medicaid Services (CMS) issued temporary waivers and new rules to give health plans flexibility early in the COVID-19 pandemic, these changes will impact the 2022 and 2023 Part D and Part C star ratings, according to an expert panel at the Pharmacy Quality Alliance 2021 Annual Meeting.

During the session, speaker Rex Wallace, MBA, outlined some changes for the star ratings and what health plans can anticipate over the next 2 years. He emphasized that the 2022 star ratings are calculated based on plans’ performances in 2020, using data collected...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: CMS, Govt Agencies, Healthcare System, Insurance, Medicare Advantage, Patient / Consumer, Payer, Pharma, Pharma / Biotech, Provider, Public Health / COVID
Related Articles:
20 top US hospitals for 2025, per Money
MGMA's perspective on CMS’s 2030 shift to value-based care
2026 Medicare Advantage rates 'inadequate,' Elevance execs say
The next 15 drugs for Medicare price negotiations
Medicare Negotiations Could Fuel, Not Stifle, Innovation

Share This Article